Biocon Q2 PAT seen up 18% at Rs 82 cr QoQ

Pharmaceutical firm Biocon is expected to report a growth of 18% quarter-on-quarter in profit after tax of Rs 82 crore in the quarter ended September 2011. The company had reported net profit of Rs 70 crore in the previous quarter.

October 19, 2011 / 12:38 IST

26 Aug, 2025 12:21

Volume

Todays L/H

Pharmaceutical firm Biocon is expected to report a growth of 18% quarter-on-quarter in profit after tax of Rs 82 crore in the quarter ended September 2011. The company had reported net profit of Rs 70 crore in the previous quarter.

Revenues are seen going up by 9% to Rs 484 crore from Rs 443 crore quarter-on-quarter.

Earnings before interest, tax, depreciation and amortisation are likely to go up by 14% to Rs 139 crore from Rs 122 crore during the same period. Operating profit margin is expected to be at 28.8% as against 27.5%.

Second quarter expectations included numbers from BioPharma and CRAMS businesses.

first published: Oct 19, 2011 08:37 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

Al Edge Newsletter On Saturdays

Find the best of Al News in one place, specially curated for you every weekend.
MC Tech 3 Newsletter Daily-Weekdays

Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347